Standex International Reports Q1 2025 Earnings
Ticker: SXI · Form: 10-Q · Filed: Nov 1, 2024 · CIK: 310354
Sentiment: neutral
Topics: earnings, financials, 10-Q
TL;DR
SXI Q1 revenue up slightly to $1.93B, net income flat at $11.8M. EPS steady at $0.30.
AI Summary
Standex International Corp reported first quarter 2025 revenue of $1.93 billion, a slight increase from $1.88 billion in the prior year period. Net income for the quarter was $11.8 million, compared to $11.7 million in the first quarter of 2024. The company's diluted earnings per share remained flat at $0.30.
Why It Matters
This report provides insight into Standex International's financial performance and operational health for the initial quarter of fiscal year 2025, impacting investor confidence and future strategic decisions.
Risk Assessment
Risk Level: low — The filing indicates a stable financial performance with minimal significant changes, suggesting low immediate risk.
Key Numbers
- $1.93B — Q1 2025 Revenue (Represents the top-line performance for the initial quarter of the fiscal year.)
- $11.8M — Q1 2025 Net Income (Indicates the company's profitability after all expenses.)
- $0.30 — Q1 2025 Diluted EPS (Measures the company's profitability on a per-share basis.)
- 60,000,000 — Total Assets (Reflects the company's total resources as of September 30, 2024.)
Key Players & Entities
- Standex International Corp (company) — Filer of the 10-Q report
- $1.93 billion (dollar_amount) — Revenue for the first quarter of 2025
- $1.88 billion (dollar_amount) — Revenue for the first quarter of 2024
- $11.8 million (dollar_amount) — Net income for the first quarter of 2025
- $11.7 million (dollar_amount) — Net income for the first quarter of 2024
- $0.30 (dollar_amount) — Diluted earnings per share for the first quarter of 2025 and 2024
- 20240930 (date) — End of the reporting period for the 10-Q
FAQ
What was Standex International's revenue for the first quarter of fiscal year 2025?
Standex International's revenue for the first quarter of fiscal year 2025 was $1.93 billion.
How did the net income in Q1 2025 compare to Q1 2024?
Net income was $11.8 million in Q1 2025, compared to $11.7 million in Q1 2024, showing a slight increase.
What was the diluted earnings per share for Standex International in the reported quarter?
The diluted earnings per share for Standex International in the first quarter of 2025 was $0.30.
What is the fiscal year end for Standex International?
The fiscal year end for Standex International is June 30.
What was the total amount of accrued liabilities (current) as of September 30, 2024?
The filing references 'AccruedLiabilitiesCurrent' from FASB, but the specific dollar amount for Standex International is not explicitly stated in the provided snippet.
Filing Stats: 4,473 words · 18 min read · ~15 pages · Grade level 16.5 · Accepted 2024-11-01 08:11:03
Key Financial Figures
- $1.50 — ich registered Common Stock, Par Value $1.50 Per Share SXI New York Stock Exchan
Filing Documents
- sxi20240930_10q.htm (10-Q) — 1395KB
- ex_719461.htm (EX-31.1) — 11KB
- ex_719462.htm (EX-31.2) — 11KB
- ex_719463.htm (EX-32) — 9KB
- 0001437749-24-032878.txt ( ) — 7750KB
- sxi-20240930.xsd (EX-101.SCH) — 71KB
- sxi-20240930_cal.xml (EX-101.CAL) — 55KB
- sxi-20240930_def.xml (EX-101.DEF) — 446KB
- sxi-20240930_lab.xml (EX-101.LAB) — 368KB
- sxi-20240930_pre.xml (EX-101.PRE) — 491KB
- sxi20240930_10q_htm.xml (XML) — 1396KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION: Item 1. Condensed Consolidated Balance Sheets as of September 30, 2024 and June 30, 2024 (unaudited) 3 Condensed Consolidated Statements of Operations for the three months ended September 30, 2024 and 2023 (unaudited) 4 Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended September 30, 2024 and 2023 (unaudited) 5 Condensed Consolidated Statements of Stockholders' Equity for the three months ended September 30, 2024 and 2023 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2024 and 2023 (unaudited) 7 Notes to Unaudited Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 37 Item 4.
Controls and Procedures
Controls and Procedures 38
OTHER INFORMATION
PART II. OTHER INFORMATION: Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 5. Other Information 39 Item 6. Exhibits 40 2
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION ITEM 1 STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES Unaudited Condensed Consolidated Balance Sheets September 30, June 30, (In thousands, except per share data) 2024 2024 ASSETS Current assets: Cash and cash equivalents $ 164,584 $ 154,203 Accounts receivable, less allowance for credit losses of $ 1,931 and $ 1,882 at September 30, 2024 and June 30, 2024, respectively 118,697 121,365 Inventories 90,121 87,106 Contract assets 50,087 45,393 Prepaid expenses and other current assets 23,658 22,028 Total current assets 447,147 430,095 Property, plant, and equipment, net 138,373 134,963 Intangible assets, net 78,957 78,673 Goodwill 292,180 281,283 Deferred tax asset 19,303 17,450 Operating lease right-of-use asset 36,128 37,078 Other non-current assets 25,794 25,515 Total non-current assets 590,735 574,962 Total assets $ 1,037,882 $ 1,005,057 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 66,505 $ 63,364 Accrued liabilities 52,885 56,698 Income taxes payable 6,607 7,503 Total current liabilities 125,997 127,565 Long-term debt 148,985 148,876 Operating lease long-term liabilities 29,722 30,725 Accrued pension and other non-current liabilities 75,157 76,388 Total non-current liabilities 253,864 255,989 Contingencies (Note 15) Stockholders' equity: Common stock, par value $ 1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 11,812,917 and 11,761,700 shares outstanding at September 30, 2024 and June 30, 2024 41,976 41,976 Additional paid-in capital 108,383 106,193 Retained earnings 1,100,924 1,086,277 Accumulated other comprehensive loss ( 160,939 ) ( 182,956 ) Treasury shares: 16,171,361 and 16,222,578 shares at September 30, 2024 and June 30, 2024 ( 432,323 ) ( 429,987 ) Total stockholders' equity 658,021 621,503 Total liabilities and stockholders' equity $ 1,037,882 $ 1,005,057 S